Hospital admission rates and costs for IBD show an increasing trend assessed by specific pharmaceutical and disease features [ 15 – 19 , 21 – 26 ].
← all excerpts
Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
1
—
—